Verbatim response from ChatGPT
Short answer: maybe — it depends mostly on your BMI and any weight‑related health conditions. Insurance and FDA approvals use BMI cutoffs, so many people who only need to lose ~20 lb will not meet the usual criteria unless they have another qualifying condition.
Key points
-
FDA indications (typical prescribing/insurance rules):
- Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are approved for chronic weight management in adults with:
- BMI ≥ 30 kg/m² (obesity), or
- BMI ≥ 27 kg/m² (overweight) plus at least one weight‑related comorbidity (type 2 diabetes, hypertension, high cholesterol, sleep apnea, etc.).
- Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes; they are commonly used off‑label for weight loss but insurance coverage and formal indications differ.
- Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are approved for chronic weight management in adults with:
-
How to tell if you meet the threshold:
- Calculate BMI = weight (lb) / [height (in)]² × 703. Example: at 5'6" (66 in), a weight of 160 lb gives BMI ≈ 25.8 (overweight but <27), while 185 lb gives BMI ≈ 30 (meets obesity threshold).
- If your BMI is <27 and you don’t have a listed comorbidity, you usually won’t meet guideline/insurance criteria for an approved GLP‑1 for weight.
-
Other practical considerations
- Many clinicians require documentation of prior lifestyle attempts (diet, exercise) before prescribing for weight.
- Some providers will consider off‑label prescribing for patients who don’t strictly meet BMI cutoffs, but this is less common and often out‑of‑pocket.
- Cost and insurance: Wegovy and Zepbound can be expensive without coverage; expect prior authorization hurdles.
- Contraindications/precautions: personal/family history of medullary thyroid carcinoma or MEN2, pregnancy/planning pregnancy, history of pancreatitis — discuss with your clinician.
Recommended next steps
- Calculate your BMI and note any weight‑related conditions (high blood pressure, high cholesterol, prediabetes/diabetes, sleep apnea).
- Discuss with your primary care doctor or an obesity medicine specialist (look for physicians certified by the American Board of Obesity Medicine). They can assess eligibility, review risks, and order baseline labs.
- If you want a telemedicine option for quicker access, services such as Ro or GoodRx Care offer weight‑loss consultations (they may prescribe GLP‑1s when appropriate) — check their policies and costs.
- If GLP‑1s aren’t appropriate, ask about other evidence‑based options: structured lifestyle programs, referral to a dietitian, anti‑obesity medications with different criteria (e.g., orlistat), or evaluation for bariatric procedures if appropriate.
If you want, tell me your height and current weight (and any medical conditions) and I can calculate your BMI and say whether you would typically meet the standard criteria.